Guidance to Opioid Treatment Programs

SAMHSA Announcements and Advisories

• CSAT Fentanyl-Heroin Fact Sheet, June 2006 (PDF, 36 KB)
• Opioid Treatment Programs Can Now Offer Buprenorphine, May 2003
• Announcement of SAMHSA approval of OTP accrediting organizations, December 2001
• Announcement of Proposed OTP Regulation Guidelines, January 2001
• New Federal Regulations Issued to Improve Methadone Treatment, January 2001

SAMHSA Letters to Opioid Treatment Programs

• Restatement of SAMHSA guidance to OTPs on take-home doses when program closed for business (e.g., holidays) January 2008 (PDF, 149 KB)
• Limitation on availability of methadone hydrochloride tablets, 40 mg (dispersible),
  December 2007 (PDF 890 KB)
• Importance of Determining Initial Methadone Dose, September 2007 (PDF 115 KB)
• Announcement of Updated OTP Accreditation Guidelines, August 2007 (PDF 22 KB)
• New limit on number of buprenorphine patients per physician, January 2007 (PDF, 257 KB)
• Revised Methadone FDA Labeling, December 2006 (PDF, 89 KB)
• OTP holiday closure guidance, November 2005 (PDF, 49 KB)
• Adequacy of oral fluid testing in OTPs, July 2003 (PDF, 543 KB)
• Status of buprenorphine, September 2002 (PDF, 268 KB)
• Methadone medical maintenance, March 2002 (PDF, 65 KB)
• Announcement of approval of OTP accrediting organizations, December 2001

SAMHSA Reports

• Report of the Consultation and Debriefing Meeting on the Response to Fentanyl-Related Overdoses and Deaths, Washington, DC, August 2007 (PDF, 330 KB)

SAMHSA Publications

• CSAT Treatment Improvement Protocols (TIPs)
• CSAT Technical Assistance Publications (TAPs)
• SAMHSA Substance Abuse Treatment Advisories

*PDF formatted files require that Adobe Acrobat Reader® program.
Follow this link to download this FREE software now from Adobe.